A multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with advanced gastric cancer.

被引：0
|
作者：
Terazawa, Tetsuji
Iwasa, Satoru
Sasaki, Yusuke
Okazaki, Shunsuke
Goto, Masahiro
Kojima, Yasushi
Naganuma, Atsushi
Nagashima, Kengo
Hirano, Hidekazu
Honma, Yoshitaka
Takashima, Atsuo
Kato, Ken
Hamaguchi, Tetsuya
机构：
[1] Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Osaka, Japan
[2] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan
[3] Kyoto Med Ctr, Div Med Oncol, Kyoto, Japan
[4] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan
[5] Natl Hosp Org, Takasaki Gen Med Ctr, Dept Gastroenterol, Takasaki, Gunma, Japan
[6] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
157
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Shirao, K
    Matsumura, Y
    Gotoh, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (12) : 2207 - 2212
  • [32] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
    Ajani, JA
    Lec, FC
    Singh, DA
    Haller, DG
    Lenz, HJ
    Benson, AB
    Yanagilhara, R
    Phan, AT
    Yao, JC
    Strumberg, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 663 - 667
  • [33] A phase II study of biweekly oxaliplatin and S-1(SOX) as first-line combination therapy in patients with advanced gastric cancer.
    Deng, Jing
    Shi, Genming
    Zheng, Yulong
    Qian, Jiong
    Jiang, Haiping
    Mao, Chenyu
    Zhang, Xiaochen
    Wang, Yao
    Xu, Nong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer
    Yoshida, Kazuhiro
    Ninomiya, Motoki
    Takakura, Norihisa
    Hirabayashi, Naoki
    Takiyama, Wataru
    Sato, Yuji
    Todo, Satoru
    Terashima, Masanori
    Gotoh, Mitsukazu
    Sakamoto, Jyunnichi
    Nishiyama, Masahiko
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3402 - 3407
  • [35] Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study
    Lenz, Heinz-Joseph
    Lee, Fa-Chyi
    Haller, Daniel G.
    Singh, Deepti
    Benson, A. B., III
    Strumberg, Dirk
    Yanagihara, Ronald
    Yao, James C.
    Phan, Alexandra T.
    Ajani, Jaffer A.
    CANCER, 2007, 109 (01) : 33 - 40
  • [36] A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen
    Sato Y.
    Kondo H.
    Honda K.
    Takahari D.
    Sumiyoshi T.
    Tsuji Y.
    Yoshizaki N.
    Niitsu Y.
    International Journal of Clinical Oncology, 2005, 10 (1) : 40 - 44
  • [37] First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
    Akitaka Makiyama
    Kenji Kunieda
    Masaaki Noguchi
    Takeshi Kajiwara
    Takao Tamura
    Koji Takeda
    Junko Sugiyama
    Keiko Minashi
    Toshikazu Moriwaki
    Naotoshi Sugimoto
    Michitaka Nagase
    Yuji Negoro
    Takashi Tsuda
    Hideki Shimodaira
    Naohiro Okano
    Akihito Tsuji
    Daisuke Sakai
    Kazuhiro Yanagihara
    Shinya Ueda
    Shingo Tamura
    Satoshi Otsu
    Takuya Honda
    Yuzo Matsushita
    Tatsuya Okuno
    Tomomi Kashiwada
    Akira Nozaki
    Masahide Ebi
    Hiroyuki Okuda
    Mototsugu Shimokawa
    Shuichi Hironaka
    Ichinosuke Hyodo
    Eishi Baba
    Narikazu Boku
    Kei Muro
    Taito Esaki
    Gastric Cancer, 2018, 21 : 792 - 801
  • [38] First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
    Makiyama, Akitaka
    Kunieda, Kenji
    Noguchi, Masaaki
    Kajiwara, Takeshi
    Tamura, Takao
    Takeda, Koji
    Sugiyama, Junko
    Minashi, Keiko
    Moriwaki, Toshikazu
    Sugimoto, Naotoshi
    Nagase, Michitaka
    Negoro, Yuji
    Tsuda, Takashi
    Shimodaira, Hideki
    Okano, Naohiro
    Tsuji, Akihito
    Sakai, Daisuke
    Yanagihara, Kazuhiro
    Ueda, Shinya
    Tamura, Shingo
    Otsu, Satoshi
    Honda, Takuya
    Matsushita, Yuzo
    Okuno, Tatsuya
    Kashiwada, Tomomi
    Nozaki, Akira
    Ebi, Masahide
    Okuda, Hiroyuki
    Shimokawa, Mototsugu
    Hironaka, Shuichi
    Hyodo, Ichinosuke
    Baba, Eishi
    Boku, Narikazu
    Muro, Kei
    Esaki, Taito
    GASTRIC CANCER, 2018, 21 (05) : 792 - 801
  • [39] A phase II study of oral S-1 with pharmacokinetics and pharmacogenomic investigation in advanced or recurrent gastric cancer.
    Rha, S. Y.
    Jeung, H. C.
    Kim, H. K.
    Kim, S. Y.
    Kim, S. Y.
    Lim, H. Y.
    Kong, S. J.
    Chung, H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 196S - 196S
  • [40] Phase I/II Study of S-1 plus Cisplatin Combination Chemotherapy in Patients with Advanced/Recurrent Head and Neck Cancer
    Fujii, Masato
    Tomita, Kitinobu
    Nishijima, Wataru
    Tsukuda, Mamoru
    Hasegawa, Yasuhisa
    Ishitoya, Junichi
    Yamane, Hideo
    Homma, Akihiro
    Tomita, Toshiki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 214 - 221
12345